Shopping Cart
- Remove All
Your shopping cart is currently empty
LY-402913 is a selective inhibitor of the multidrug resistance protein (MRP1).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $117 | In Stock | |
| 2 mg | $175 | In Stock | |
| 5 mg | $268 | In Stock | |
| 10 mg | $395 | In Stock | |
| 25 mg | $592 | In Stock | |
| 50 mg | $828 | In Stock | |
| 100 mg | $1,130 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $337 | In Stock |
| Description | LY-402913 is a selective inhibitor of the multidrug resistance protein (MRP1). |
| In vitro | LY-402913 inhibits MRP1 and reverses drug resistance to MRP1 substrates, such as doxorubicin, in HeLa-T5 cells (EC50=0.90 μM), while showing no inherent cytotoxicity. LY-402913 inhibits ATP-dependent, MRP1-mediated LTC4 uptake into membrane vesicles prepared from the MRP1-overexpressing HeLa-T5 cells (EC50=1.8 μM). LY-402913 also shows selectivity (∼22-fold) against the related transporter, P-glycoprotein, in HL60/Adr and HL60/Vinc cells[2]. |
| In vivo | When dosed in combination with the oncolytic MRP1 substrate vincristine, LY-402913 delays the growth of MRP1-overexpressing tumors in vivo[2]. |
| Synonyms | LY402913, LY 402913 |
| Molecular Weight | 533.96 |
| Formula | C28H24ClN3O6 |
| Cas No. | 334970-65-9 |
| Smiles | O=C1N(C=2C(C3=C1C(C)=NO3)=C(Cl)C=CC2)C4=CC(CC(NC5=CC(OC)=C(OC)C(OC)=C5)=O)=CC=C4 |
| Relative Density. | 1.376 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (93.64 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.